RESELIGO 3.6mg implant in pre-filled syringe medication leaflet

L02AE03 • goserelin • Antineoplastic and immunomodulating agents | Hormones and related agents | Gonadotropin releasing hormone analogues

Goserelin is a medication mainly used in the treatment of prostate cancer in men and breast cancer in women, as well as in some gynecological conditions such as endometriosis. It works by reducing the levels of certain hormones in the body, which helps slow down or stop the growth of cancer cells or abnormal tissue.

The medication is administered as a subcutaneous implant, usually once every few weeks or months, depending on your doctor's instructions. The treatment is closely monitored to assess effectiveness and adjust the dose if necessary.

Side effects may include hot flashes, sweating, decreased libido, mood changes, bone pain, or reactions at the implant site. In some cases, allergic reactions or changes in bone density may occur. Any unusual symptoms should be reported to your doctor.

Goserelin is an effective medication for controlling certain types of cancer and hormonal conditions, but it requires strict medical supervision. Follow the administration schedule and your doctor's instructions to achieve the best results and minimize risks.